Patent issue in focus
The year 2001 saw the pharmaceuticals sector lose some of its glitter. After years of uninterrupted double-digit earnings growth that lent a gilt edged feel to pharmaceutical shares, some of the
The year 2001 saw the pharmaceuticals sector lose some of its glitter. After years of uninterrupted double-digit earnings growth that lent a gilt edged feel to pharmaceutical shares, some of the